GAO report finds little evidence supporting pharmacy-only class of drugs.
This article was originally published in The Tan Sheet
Executive Summary
GAO FINDS THIRD CLASS OF DRUGS NOT SUPPORTED BY AVAILABLE EVIDENCE in a report released Aug. 24. At the request of Rep. John Dingell (D-Mich.) in 1992, GAO conducted an assessment of "the evidence for creating an additional class of drugs in the U.S. that would not be for sale outside pharmacies but would be available without a physician's prescription." The report concludes that "little evidence supports the establishment of a pharmacy or pharmacist class of drugs in the U.S. at this time."
You may also be interested in...
Third Class Of Drugs Should Not Be “Completely Closed Down” – Ganley
Debate on the merits of a third class of drugs could resurface as FDA considers Rx-to-OTC switch applications of drugs indicated for chronic conditions
Third Class Of Drugs Should Not Be “Completely Closed Down” – Ganley
Debate on the merits of a third class of drugs could resurface as FDA considers Rx-to-OTC switch applications of drugs indicated for chronic conditions
Third Class Of Drugs Should Not Be “Completely Closed Down” – Ganley
Debate on the merits of a third class of drugs could resurface as FDA considers Rx-to-OTC switch applications of drugs indicated for chronic conditions